Differential effects of enzyme induction on antipyrine metabolite formation
- PMID: 7059438
- PMCID: PMC1402128
- DOI: 10.1111/j.1365-2125.1982.tb01389.x
Differential effects of enzyme induction on antipyrine metabolite formation
Abstract
1 The influence of enzyme induction with antipyrine and pentobarbitone was studied on the rates of formation of the major metabolites of antipyrine: 4-hydroxyantipyrine, norantipyrine and 3-hydroxymethyl-antipyrine + 3-carboxy-antipyrine. The inducing drugs were given to panels of healthy volunteers for 8 days and prior to and after this period antipyrine total elimination clearance was determined in plasma, whereas the partial clearances for production of the individual metabolites were assessed on the basis of urinary excretion data. 2 Antipyrine total clearance had significantly increased by 16% following treatment with antipyrine, which could almost entirely be attributed to a selective increase in the rate of production of norantipyrine. 3 With pentobarbitone total clearance of antipyrine had increased by 60%, which was associated with a significant increase in the clearance of production of all three metabolites. However, the increase in norantipyrine formation was significantly higher than the increase in 4-hydroxyantipyrine and 3-hydroxymethyl-antipyrine formation. 4 The most likely explanation for these differences in the degree of induction of the different metabolic routes of antipyrine, is that different enzymes are involved in the different routes. Apparently the enzyme involved in norantipyrine formation is most sensitive to induction by antipyrine and pentobarbitone. By measuring rates of antipyrine metabolite formation it may be possible to study the degree of selectivity of enzyme inducers on oxidative drug metabolism.
Similar articles
-
Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.Clin Pharmacol Ther. 1996 Jun;59(6):613-23. doi: 10.1016/S0009-9236(96)90001-6. Clin Pharmacol Ther. 1996. PMID: 8681486
-
Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.Pharmacology. 1981;22(6):349-58. doi: 10.1159/000137515. Pharmacology. 1981. PMID: 7267701
-
Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin.Xenobiotica. 1992 Nov;22(11):1243-50. doi: 10.3109/00498259209053153. Xenobiotica. 1992. PMID: 1492417
-
Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.Br J Clin Pharmacol. 1985 Dec;20(6):611-8. doi: 10.1111/j.1365-2125.1985.tb05119.x. Br J Clin Pharmacol. 1985. PMID: 4091993 Free PMC article.
-
Metronidazole and antipyrine as probes for the study of foreign compound metabolism.Pharmacol Toxicol. 1990;66 Suppl 6:1-31. doi: 10.1111/j.1600-0773.1990.tb01611.x. Pharmacol Toxicol. 1990. PMID: 2184425 Review.
Cited by
-
Metabolism of the aldose reductase inhibitor ALO1567 in man.Br J Clin Pharmacol. 1991 Aug;32(2):221-7. doi: 10.1111/j.1365-2125.1991.tb03885.x. Br J Clin Pharmacol. 1991. PMID: 1931471 Free PMC article. Clinical Trial.
-
Assessment of the drug metabolism capacity of the liver.Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x. Br J Clin Pharmacol. 1982. PMID: 6128018 Free PMC article. Review. No abstract available.
-
The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172.Br J Clin Pharmacol. 1991 Jul;32(1):23-9. doi: 10.1111/j.1365-2125.1991.tb05608.x. Br J Clin Pharmacol. 1991. PMID: 1716140 Free PMC article.
-
Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.Br J Clin Pharmacol. 1984 Nov;18(5):701-6. doi: 10.1111/j.1365-2125.1984.tb02532.x. Br J Clin Pharmacol. 1984. PMID: 6508979 Free PMC article.
-
Differential effect of type I and type II diabetes on antipyrine disposition in man.Eur J Clin Pharmacol. 1988;34(4):369-75. doi: 10.1007/BF00542438. Eur J Clin Pharmacol. 1988. PMID: 3402522
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources